Decrease in sigma but no increase in striatal dopamine D sub(4) sites in schizophrenic brains

[ super(3)H]Nemonapride differentially defines sigma and dopamine receptor sites depending upon assay conditions. In post-mortem schizophrenic brain tissues, [ super(3)H]nemonapride-labeled sigma receptor binding is decreased compared to matched normal controls. No striatal dopamine D sub(4)/D sub(4...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmacology 1996-10, Vol.314 (3), p.R3-R5
Main Authors: Helmeste, D M, Tang, Siu W, Bunney, WE Jr, Potkin, S G, Jones, E G
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page R5
container_issue 3
container_start_page R3
container_title European journal of pharmacology
container_volume 314
creator Helmeste, D M
Tang, Siu W
Bunney, WE Jr
Potkin, S G
Jones, E G
description [ super(3)H]Nemonapride differentially defines sigma and dopamine receptor sites depending upon assay conditions. In post-mortem schizophrenic brain tissues, [ super(3)H]nemonapride-labeled sigma receptor binding is decreased compared to matched normal controls. No striatal dopamine D sub(4)/D sub(4)-like receptor differential was observed between the schizophrenic or control tissues, using the [ super(3)H]nemonapride minus [ super(3)H]raclopride subtraction method.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_16454231</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16454231</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_164542313</originalsourceid><addsrcrecordid>eNqNi70KwjAURjMoWH_eIZPoUEjbVMhsFR_AVcptvNpImtTcdPHpLeLg6PRxOOebsESITKa5UmrG5kQPIUSp8jJhlwp1QCDkxnEy9w54M0Tu_Mg_IgYDESy_-h4645BXnIZmI7fjJyJ9Gt2al-_bgM5o3gQwjpZsegNLuPrugq2Ph_P-lPbBPwekWHeGNFoLDv1AdbaTpcyLrPg7fAPgVUWf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16454231</pqid></control><display><type>article</type><title>Decrease in sigma but no increase in striatal dopamine D sub(4) sites in schizophrenic brains</title><source>Elsevier</source><creator>Helmeste, D M ; Tang, Siu W ; Bunney, WE Jr ; Potkin, S G ; Jones, E G</creator><creatorcontrib>Helmeste, D M ; Tang, Siu W ; Bunney, WE Jr ; Potkin, S G ; Jones, E G</creatorcontrib><description>[ super(3)H]Nemonapride differentially defines sigma and dopamine receptor sites depending upon assay conditions. In post-mortem schizophrenic brain tissues, [ super(3)H]nemonapride-labeled sigma receptor binding is decreased compared to matched normal controls. No striatal dopamine D sub(4)/D sub(4)-like receptor differential was observed between the schizophrenic or control tissues, using the [ super(3)H]nemonapride minus [ super(3)H]raclopride subtraction method.</description><identifier>ISSN: 0014-2999</identifier><language>eng</language><ispartof>European journal of pharmacology, 1996-10, Vol.314 (3), p.R3-R5</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Helmeste, D M</creatorcontrib><creatorcontrib>Tang, Siu W</creatorcontrib><creatorcontrib>Bunney, WE Jr</creatorcontrib><creatorcontrib>Potkin, S G</creatorcontrib><creatorcontrib>Jones, E G</creatorcontrib><title>Decrease in sigma but no increase in striatal dopamine D sub(4) sites in schizophrenic brains</title><title>European journal of pharmacology</title><description>[ super(3)H]Nemonapride differentially defines sigma and dopamine receptor sites depending upon assay conditions. In post-mortem schizophrenic brain tissues, [ super(3)H]nemonapride-labeled sigma receptor binding is decreased compared to matched normal controls. No striatal dopamine D sub(4)/D sub(4)-like receptor differential was observed between the schizophrenic or control tissues, using the [ super(3)H]nemonapride minus [ super(3)H]raclopride subtraction method.</description><issn>0014-2999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqNi70KwjAURjMoWH_eIZPoUEjbVMhsFR_AVcptvNpImtTcdPHpLeLg6PRxOOebsESITKa5UmrG5kQPIUSp8jJhlwp1QCDkxnEy9w54M0Tu_Mg_IgYDESy_-h4645BXnIZmI7fjJyJ9Gt2al-_bgM5o3gQwjpZsegNLuPrugq2Ph_P-lPbBPwekWHeGNFoLDv1AdbaTpcyLrPg7fAPgVUWf</recordid><startdate>19961001</startdate><enddate>19961001</enddate><creator>Helmeste, D M</creator><creator>Tang, Siu W</creator><creator>Bunney, WE Jr</creator><creator>Potkin, S G</creator><creator>Jones, E G</creator><scope>7TK</scope></search><sort><creationdate>19961001</creationdate><title>Decrease in sigma but no increase in striatal dopamine D sub(4) sites in schizophrenic brains</title><author>Helmeste, D M ; Tang, Siu W ; Bunney, WE Jr ; Potkin, S G ; Jones, E G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_164542313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Helmeste, D M</creatorcontrib><creatorcontrib>Tang, Siu W</creatorcontrib><creatorcontrib>Bunney, WE Jr</creatorcontrib><creatorcontrib>Potkin, S G</creatorcontrib><creatorcontrib>Jones, E G</creatorcontrib><collection>Neurosciences Abstracts</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Helmeste, D M</au><au>Tang, Siu W</au><au>Bunney, WE Jr</au><au>Potkin, S G</au><au>Jones, E G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decrease in sigma but no increase in striatal dopamine D sub(4) sites in schizophrenic brains</atitle><jtitle>European journal of pharmacology</jtitle><date>1996-10-01</date><risdate>1996</risdate><volume>314</volume><issue>3</issue><spage>R3</spage><epage>R5</epage><pages>R3-R5</pages><issn>0014-2999</issn><abstract>[ super(3)H]Nemonapride differentially defines sigma and dopamine receptor sites depending upon assay conditions. In post-mortem schizophrenic brain tissues, [ super(3)H]nemonapride-labeled sigma receptor binding is decreased compared to matched normal controls. No striatal dopamine D sub(4)/D sub(4)-like receptor differential was observed between the schizophrenic or control tissues, using the [ super(3)H]nemonapride minus [ super(3)H]raclopride subtraction method.</abstract></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 1996-10, Vol.314 (3), p.R3-R5
issn 0014-2999
language eng
recordid cdi_proquest_miscellaneous_16454231
source Elsevier
title Decrease in sigma but no increase in striatal dopamine D sub(4) sites in schizophrenic brains
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T16%3A04%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decrease%20in%20sigma%20but%20no%20increase%20in%20striatal%20dopamine%20D%20sub(4)%20sites%20in%20schizophrenic%20brains&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Helmeste,%20D%20M&rft.date=1996-10-01&rft.volume=314&rft.issue=3&rft.spage=R3&rft.epage=R5&rft.pages=R3-R5&rft.issn=0014-2999&rft_id=info:doi/&rft_dat=%3Cproquest%3E16454231%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_164542313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16454231&rft_id=info:pmid/&rfr_iscdi=true